Lokhorst HM - Search Results

1

Graft-versus-myeloma effect in two cases.

Verdonck LF, Lokhorst HM, Dekker AW, Nieuwenhuis HK, Petersen EJ. Verdonck LF, et al. Among authors: lokhorst hm. Lancet. 1996 Mar 23;347(9004):800-1. doi: 10.1016/s0140-6736(96)90871-5. Lancet. 1996. PMID: 8622337

2

The occurrence of graft-versus-host disease is the major predictive factor for response to donor lymphocyte infusions in multiple myeloma.

Lokhorst HM, Wu K, Verdonck LF, Laterveer LL, van de Donk NW, van Oers MH, Cornelissen JJ, Schattenberg AV. Lokhorst HM, et al. Blood. 2004 Jun 1;103(11):4362-4. doi: 10.1182/blood-2003-11-3862. Epub 2004 Feb 19. Blood. 2004. PMID: 14976044 Free article.

3

Advances in the treatment of multiple myeloma.

Lokhorst HM, Dekker AW. Lokhorst HM, et al. Cancer Treat Rev. 1993 Apr;19(2):113-28. doi: 10.1016/0305-7372(93)90030-u. Cancer Treat Rev. 1993. PMID: 7683253 Review. No abstract available.

4

Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graft.

Verdonck LF, Dekker AW, de Gast GC, van Kempen ML, Lokhorst HM, Nieuwenhuis HK. Verdonck LF, et al. Among authors: lokhorst hm. Blood. 1994 May 15;83(10):3090-6. Blood. 1994. PMID: 8180405 Free article.

5

Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma.

Verdonck LF, Dekker AW, Lokhorst HM, Petersen EJ, Nieuwenhuis HK. Verdonck LF, et al. Among authors: lokhorst hm. Blood. 1997 Nov 15;90(10):4201-5. Blood. 1997. PMID: 9354692 Free article.

6

Donor leukocyte infusions are effective in relapsed multiple myeloma after allogeneic bone marrow transplantation.

Lokhorst HM, Schattenberg A, Cornelissen JJ, Thomas LL, Verdonck LF. Lokhorst HM, et al. Blood. 1997 Nov 15;90(10):4206-11. Blood. 1997. PMID: 9354693 Free article.

7

Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor T cells.

Verdonck LF, Petersen EJ, Lokhorst HM, Nieuwenhuis HK, Dekker AW, Tilanus MG, de Weger RA. Verdonck LF, et al. Among authors: lokhorst hm. Bone Marrow Transplant. 1998 Dec;22(11):1057-63. doi: 10.1038/sj.bmt.1701496. Bone Marrow Transplant. 1998. PMID: 9877267

8

Donor leukocyte infusions inducing remissions repeatedly in a patient with recurrent multiple myeloma after allogeneic bone marrow transplantation.

van der Griend R, Verdonck LF, Petersen EJ, Veenhuizen P, Bloem AC, Lokhorst HM. van der Griend R, et al. Among authors: lokhorst hm. Bone Marrow Transplant. 1999 Jan;23(2):195-7. doi: 10.1038/sj.bmt.1701546. Bone Marrow Transplant. 1999. PMID: 10197809

9

Intensive treatment for multiple myeloma: where do we stand?

Lokhorst HM, Sonneveld P, Verdonck LF. Lokhorst HM, et al. Br J Haematol. 1999 Jul;106(1):18-27. doi: 10.1046/j.1365-2141.1999.01406.x. Br J Haematol. 1999. PMID: 10444158 Free article. Review. No abstract available.

10

Donor lymphocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: predictive factors for response and long-term outcome.

Lokhorst HM, Schattenberg A, Cornelissen JJ, van Oers MH, Fibbe W, Russell I, Donk NW, Verdonck LF. Lokhorst HM, et al. J Clin Oncol. 2000 Aug;18(16):3031-7. doi: 10.1200/JCO.2000.18.16.3031. J Clin Oncol. 2000. PMID: 10944138

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

244 results

Search Page

Filters